clinical trial · NCT07100418
A Clinical Study Evaluating the Efficacy and Safety of HRS-7249 in Treating Patients With Hyperlipidemia
Fujian Shengdi Pharmaceutical Co., Ltd.·phase2·active not recruiting·n = 224
HyperlipidemiaHRS-7249 InjectionSodium Chloride Injection
brief summary
The study is being conducted to evaluate the efficacy and safety of HRS-7249 for patients with hyperlipidemia, and to explore the reasonable dosage of HRS-7249 for patients with hyperlipidemia.
started
Aug 12, 2025
primary completion
Sep 1, 2026
completion
Jan 1, 2027
last updated
Jun 3, 2026
official title
A Multicenter, Randomized, Placebo-controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of HRS-7249 in Patients With Hyperlipidemia
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol